Patents by Inventor Thomas Fork

Thomas Fork has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PER-ORAL NEGATIVE CONTRAST AGENT FOR ABDOMINAL IMAGING
    Publication number: 20220125955
    Abstract: An edible negative contrast agent for CT imaging of the gastrointestinal tract intended for oral intake. The contrast agent is a fluid, aqueous foam displaying a CT density contrast value in the range ?300 to ?800 HU and having a consistency of 7 to 12 cm as measured with Bostwick consistometer. The contrast agent comprises an aqueous continuous liquid phase having a pH of 6.5 to 8.0 and gas bubbles dispersed in the continuous aqueous liquid phase. The aqueous continuous liquid phase comprises a surfactant, the surfactant being a protein, a hydrocolloid acting as foam stabilizer, a buffering agent, and water.
    Type: Application
    Filed: October 15, 2021
    Publication date: April 28, 2022
    Inventors: Lucia Casal-Dujat, Olof Böök, Ingvar Adnerhill, Rickard Öste, Thomas Fork
  • Per-oral negative contrast agent for abdominal CT
    Patent number: 11179483
    Abstract: An edible negative contrast agent for CT imaging of the gastrointestinal tract intended for oral intake. The contrast agent is a fluid, aqueous foam displaying a CT density contrast value in the range ?300 to ?800 HU and having a consistency of 7 to 12 cm as measured with Bostwick consistometer. The contrast agent comprises an aqueous continuous liquid phase having a pH of 6.5 to 8.0 and gas bubbles dispersed in the continuous aqueous liquid phase. The aqueous continuous liquid phase comprises a surfactant, the surfactant being a protein, a hydrocolloid acting as foam stabilizer, a buffering agent, and water.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: November 23, 2021
    Assignee: LUMENTAB
    Inventors: Lucia Casal-Dujat, Olof Böök, Ingvar Adnerhill, Rickard Öste, Thomas Fork
  • PER-ORAL NEGATIVE CONTRAST AGENT FOR ABDOMINAL CT
    Publication number: 20200000942
    Abstract: An edible negative contrast agent for CT imaging of the gastrointestinal tract intended for oral intake. The contrast agent is a fluid, aqueous foam displaying a CT density contrast value in the range ?300 to ?800 HU and having a consistency of 7 to 12 cm as measured with Bostwick consistometer. The contrast agent comprises an aqueous continuous liquid phase having a pH of 6.5 to 8.0 and gas bubbles dispersed in the continuous aqueous liquid phase. The aqueous continuous liquid phase comprises a surfactant, the surfactant being a protein, a hydrocolloid acting as foam stabilizer, a buffering agent, and water.
    Type: Application
    Filed: February 26, 2018
    Publication date: January 2, 2020
    Inventors: Lucia Casal-Dujat, Olof Böök, Ingvar Adnerhill, Rickard Öste, Thomas Fork